Merck
CN
  • Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene.

Three siblings with Cerebrotendinous Xanthomatosis: a novel mutation in the CYP27A1 gene.

European journal of medical genetics (2011-10-01)
Sunghwan Suh, Hee Kyung Kim, Hyung-Doo Park, Chang-Seok Ki, Mi Yeon Kim, Sang-Man Jin, Se Won Kim, Kyu Yeon Hur, Kwang-Won Kim, Jae Hyeon Kim
摘要

Cerebrotendinous Xanthomatosis (CTX) is a rare autosomal recessive lipid storage disease caused by sterol 27-hydroxylase (CYP27) deficiency. We report three CTX siblings that shared a novel mutation of the CYP27A1 gene. These siblings presented with elevated cholestanol levels and typical manifestations such as tendon xanthomas, cataracts, osteopenia, mental retardation, cerebellar ataxia and peripheral neuropathy. All shared the same genetic mutation, c.1146_1151delins and c.1214G>A of CYP27A1. All were treated with 750 mg/day chenodeoxycholic acid (CDCA). In conclusion, one should consider the possibility of CTX in any individual with normocholesterolemic xanthomatosis, early-onset cataracts, mental retardation, cerebellar ataxia and peripheral neuropathy.

材料
货号
品牌
产品描述

Sigma-Aldrich
αβ二氢胆固醇, ≥95%
Sigma-Aldrich
5β-胆甾烷-3α-醇, ≥95%
Sigma-Aldrich
粪甾烷-3-醇, ≥98%
Supelco
胆甾烷醇, certified reference material, 10 mg/mL in chloroform